Dementia: Medications, Blood Tests, and AI Early Detection Breakthroughs
Researchers are increasingly turning to AI-driven diagnostics and blood-based biomarkers to improve the early detection of dementia, a shift that could fundamentally change how clinicians approach neurodegenerative conditions. While current diagnostic processes often rely on late-stage clinical symptoms, new diagnostic tools aim to identify biological changes years before cognitive decline becomes apparent. According to the … Read more